[ Price : $8.95]
FDA clears Sonic Incytes Velacur Determined Fat Fraction measuring tool.[ Price : $8.95]
Federal Register notice: FDA announces that it approved Incytes Opzelura (ruxolitinib) using a rare pediatric disease priority rev...[ Price : $8.95]
CDER director Patrizia Cavazzoni tells a drug regulatory conference that FDA is considering more opportunities for sponsors to lea...[ Price : $8.95]
Federal Register notice: FDA classifies endoscopic pancreatic debridement devices into Class 2 (special controls).[ Price : $8.95]
CBER posts an updated standard operating policy and procedure (SOPP) manual entitled SOPP 8404: Refusal to File (RTF) Procedures. ...[ Price : $8.95]
Federal Register notice: FDA classifies blood collection devices for cell-free nucleic acids into Class 2.[ Price : $8.95]
GSK says data from two clinical trials showed that depemokimab significantly reduces asthma exacerbations in patients with severe ...[ Price : $8.95]
FDA removes a partial clinical hold against Rezolutes RZ358 (ersodetug), an investigational drug for treating hypoglycemia caused ...